May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Combined Intravitreal Bevacizumab and Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Age Related Macular Degeneration
M. S. Dhalla; G. K. Shah; K. J. Blinder; E. H. Ryan, Jr.; R. A. Mittra; A. Tewari
Author Affiliations & Notes
  • M. S. Dhalla
    Washington Univ School of Medicine, Ophthal and Visual Sciences, Barnes Retina Institute, St. Louis, Missouri
  • G. K. Shah
    Washington Univ School of Medicine, Ophthal and Visual Sciences, Barnes Retina Institute, St. Louis, Missouri
  • K. J. Blinder
    Washington Univ School of Medicine, Ophthal and Visual Sciences, Barnes Retina Institute, St. Louis, Missouri
  • E. H. Ryan, Jr.
    Washington Univ School of Medicine, Ophthal and Visual Sciences, Barnes Retina Institute, St. Louis, Missouri
  • R. A. Mittra
    Washington Univ School of Medicine, Ophthal and Visual Sciences, Barnes Retina Institute, St. Louis, Missouri
  • A. Tewari
    Washington Univ School of Medicine, Ophthal and Visual Sciences, Barnes Retina Institute, St. Louis, Missouri
  • Footnotes
    Commercial Relationships M.S. Dhalla, None; G.K. Shah, None; K.J. Blinder, None; E.H. Ryan, None; R.A. Mittra, None; A. Tewari, None.
  • Footnotes
    Support None.
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3389. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Combined Intravitreal Bevacizumab and Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Age Related Macular Degeneration
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      M. S. Dhalla, G. K. Shah, K. J. Blinder, E. H. Ryan, Jr., R. A. Mittra, A. Tewari; Combined Intravitreal Bevacizumab and Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Age Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3389.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose:: To report the 12-month results for patients treated with combined photodynamic therapy (PDT) with verteporfin and intravitreal bevacizumab for choroidal neovascularization secondary to age related macular degeneration (AMD).

Methods:: This is a retrospective review of 24 treatment naïve eyes that received intravitreal bevacizumab and PDT with verteporfin within a 14 day interval.

Results:: Main outcome measures will be visual acuity stabilization (defined as no change in visual acuity or a gain in visual acuity) and retreatment rate.

Conclusions:: The results of this study will be helpful in defining what future role combination therapy may play in the treatment of neovascular AMD.Data will be available in January 2007.

Keywords: choroid: neovascularization • age-related macular degeneration • growth factors/growth factor receptors 
© 2007, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept